Related Experiment Video
Updated: Jul 10, 2025
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
Optimal Strategies for Managing Prostate-specific Antigen Recurrence After Primary Radiotherapy in Prostate Cancer:
Heikki Seikkula1, Lauri Mäkelä2, Harri Visapää2
1Department of Surgery, Central Finland Wellbeing Services/Hospital Nova, Jyväskylä, Finland.
European Urology Focus
|November 21, 2023
Abstract:
Biochemical recurrence after radiotherapy for prostate cancer is a clinical dilemma. Patients at low risk of disease progression can be safely monitored. In Finland, options for those with reasonable life expectancy include salvage high-dose-rate brachytherapy and transurethral ultrasound ablation under magnetic resonance imaging guidance.
